Several anthropometric and performance parameters related to aerobic metabolism are associated with performance in endurance runners and are modified according to the training performed. The ...objective of this study was to investigate the ergospirometric and body composition changes in endurance runners during a sports season in relation to their training. Twenty highly trained men endurance runners performed an incremental test until exhaustion (initial, and at 3, 6, and 9 months) on a treadmill to determine maximal oxygen consumption (VO
max), second ventilatory threshold (VT
), and their associated running speeds. Skinfolds, perimeters, and weights were measured. No changes were obtained in VO
max or VT
during the study, although their associated running speeds increased (
< 0.05) after 3 months of the study. Decreases in fat mass (
< 0.05) and muscle mass (
< 0.05) were observed at the end of the season (9 months). Changes occurred in the different skinfolds according to the characteristics of the training performed during the season. In conclusion, vVO
max and vVT
increase with a greater volume of kilometres trained and can be adversely affected by loss of muscle mass.
The aim of the present study was to evaluate the basal concentrations of malondialdehyde (MDA) nonenzymatic antioxidants, such as ascorbic acid, α-tocopherol, and retinol in plasma or erythrocytes, ...and the plasma concentrations of 16 trace minerals in endurance athletes from Extremadura (Spain). In addition, we aimed to assess the possible relationships between some parameters related to cellular oxidative stress with plasma concentrations of some trace minerals. Sixty-two national long-distance men athletes participated in this study. The parameters related to oxidative stress and antioxidant activity were analyzed through high pressure liquid chromatography (HPLC), and trace minerals analysis was performed by inductively coupled plasma mass spectrometry (ICP-MS). We found that plasma MDA was positively correlated with selenium and rubidium. Plasma ascorbic acid was positively correlated with manganese and negatively correlated with cobalt and cadmium. Erythrocyte ascorbic acid was related to arsenic and cesium. Plasma α-tocopherol correlated with copper and manganese negatively and positively with arsenic. Erythrocyte α-tocopherol was positively related to copper, rubidium, and lithium. The findings show that athletes with a high degree of training should monitor their intake and concentrations of α-tocopherol for its fundamental role of neutralizing the excess of reactive oxygen species produced by exercise and the prooxidant effects of several minerals such as arsenic, copper, and lithium.
Serum vanadium concentrations in different sports modalities Toro-Román, Víctor; Bartolomé, Ignacio; Siquier-Coll, Jesús ...
Journal of trace elements in medicine and biology,
December 2021, 2021-Dec, 2021-12-00, 20211201, Volume:
68
Journal Article
Peer reviewed
The aim of this study was to compare serum vanadium (V) concentrations between athletes of different sports modalities and people who did not practise physical exercise regularly.
One hundred and ...twenty-one subjects divided into a control group (CG; n = 37; 1.75 ± 0.03 m; 79.45 ± 10.20 kg; 24.72 ± 6.06 years) and an athletes’ group (AG; n = 84; 1.77 ± 0.05 m; 66.34 ± 6.12 kg; 19.57 ± 1.95 years) participated in this research. AG were classified by sports modality: aerobic (AE; n = 26), anaerobic (ANA; n = 22); aerobic-anaerobic (AE-ANA; n = 36). Serum V concentrations were analysed by inductively coupled plasma mass spectrometry.
AG showed higher V concentrations compared to CG (p < 0.01). AE obtained higher concentrations compared to ANA and AE-ANA (p < 0.05).
Physical training could increase serum V levels. Specifically, aerobic sports modalities could increase serum V levels to a greater extent than other sports modalities.
The catalytic performance during the 1-butyne hydrogenation using two reduced Al2O3-supported Pd-based catalysts was carried out in a total recirculation system with an external fixed-bed reactor. ...The lab-prepared egg-shell NiPd/CeO2-Al2O3 catalyst (NiPdCe) with Pd loading = 0.5 wt%, Ni/Pd atomic ratio = 1 and CeO2 loading = 3 wt% was synthesized and characterized, and it was compared with an egg-shell Al2O3-supported Pd based commercial catalyst (PdCC). The reduced catalysts were characterized by X-ray diffraction, X-ray photoelectron spectroscopy, and high-resolution transmission electron microscopy. The textural characteristics and ammonia temperature-programmed desorption profiles of the fresh (unreduced) catalysts were also obtained. Both catalysts show high 1-butyne conversion and selectivity to 1-butene, but the catalysts also present important differences between hydroisomerizing and hydrogenating capabilities. NiPdCe catalyst shows higher capability for hydroisomerization reactions, while the PdCC catalyst exhibits higher hydrogenating capability. The observed catalytic performances can be interesting for some industrial processes and can provide a guideline for the development of a Pd-based catalyst with specific catalytic properties.
The catalytic performance of an egg-shell bifunctional CeO2-modified NiPd/Al2O3 catalyst in the butyne hydrogenation was studied and compared with a promoted Pd/Al2O3 commercial catalyst. Both samples show high selectivities toward 1-butene. However, the lab-prepared catalyst displayed a higher capability for the hydroisomerization reactions, while the commercial catalyst exhibits higher hydrogenating capability. Display omitted
Polycomb proteins are known to be of great importance in human cancer pathogenesis. SUZ12 is a component of the Polycomb PRC2 complex that, along with EZH2, is involved in embryonic stem cell ...differentiation. EZH2 plays an essential role in many cancer types, but an equivalent involvement of SUZ12 has not been as thoroughly demonstrated. Here we show that SUZ12 is anomalously expressed in human primary tumors, especially in mantle cell lymphoma (MCL), pulmonary carcinomas and melanoma, and is associated with gene locus amplification in some cases. Using MCL as a model, functional and genomic studies demonstrate that SUZ12 loss compromises cell viability, increases apoptosis, and targets genes involved in central oncogenic pathways associated with MCL pathogenesis. Our results support the hypothesis that the abnormal expression of SUZ12 accounts for some of the unexplained features of MCL, such as abnormal DNA repair and increased resistance to apoptosis.
Peripheral T-cell lymphomas are very aggressive hematologic malignancies for which there is no targeted therapy. New, rational approaches are necessary to improve the very poor outcome in these ...patients. Phosphatidylinositol-3-kinase is one of the most important pathways in cell survival and proliferation. We hypothesized that phosphatidylinositol-3-kinase inhibitors could be rationally selected drugs for treating peripheral T-cell lymphomas. Several phosphatidylinositol-3-kinase isoforms were inhibited genetically (using small interfering RNA) and pharmacologically (with CAL-101 and GDC-0941 compounds) in a panel of six peripheral and cutaneous T-cell lymphoma cell lines. Cell viability was measured by intracellular ATP content; apoptosis and cell cycle changes were checked by flow cytometry. Pharmacodynamic biomarkers were assessed by western blot. The PIK3CD gene, which encodes the δ isoform of phosphatidylinositol-3-kinase, was overexpressed in cell lines and primary samples, and correlated with survival pathways. However, neither genetic nor specific pharmacological inhibition of phosphatidylinositol-3-kinase δ affected cell survival. In contrast, the pan-phosphatidylinositol-3-kinase inhibitor GDC-0941 arrested all T-cell lymphoma cell lines in the G1 phase and induced apoptosis in a subset of them. We identified phospho-GSK3β and phospho-p70S6K as potential biomarkers of phosphatidylinositol-3-kinase inhibitors. Interestingly, an increase in ERK phosphorylation was observed in some GDC -0941-treated T-cell lymphoma cell lines, suggesting the presence of a combination of phosphatidylinositol-3-kinase and MEK inhibitors. A highly synergistic effect was found between the two inhibitors, with the combination enhancing cell cycle arrest at G0/G1 in all T-cell lymphoma cell lines, and reducing cell viability in primary tumor T cells ex vivo. These results suggest that the combined treatment of pan-phosphatidylinositol-3-kinase + MEK inhibitors could be more effective than single phosphatidylinositol-3-kinase inhibitor treatment, and therefore, that this combination could be of therapeutic value for treating peripheral and cutaneous T-cell lymphomas.
The impact of intraparticle diffusion limitations on the selectivity of an industrial reactor for selective hydrogenation of 1‐butyne and 1,3‐butadiene contained in 1‐butene rich cuts was evaluated. ...To this end, a simple model of a trickle‐bed reactor was employed and actual process operating conditions were chosen. A kinetic model was chosen whose parameters correspond to a commercial catalyst. These parameters were calculated from experiments conducted under industrial operating conditions. The complex diffusion and reaction phenomena occurring inside catalyst pellets placed at different depths of the reactor are comprehensively described. 1‐Butene losses in the range 20–30 %, which are usual in commercial plants, were predicted. It was concluded that the operating pressure is crucial for enhancing process selectivity.
The impact of intraparticle diffusion limitations on the selectivity of an industrial reactor for selective hydrogenation of 1‐butyne and 1,3‐butadiene contained in 1‐butene rich cuts was evaluated. A simple model of a trickle‐bed reactor was employed and actual process operating conditions were chosen. A kinetic model was chosen whose parameters correspond to a commercial catalyst.
Despite improvement in the treatment of advanced classical Hodgkin lymphoma, approximately 30% of patients relapse or die as result of the disease. Current predictive systems, determined by clinical ...and analytical parameters, fail to identify these high-risk patients accurately. We took a multistep approach to design a quantitative reverse-transcription polymerase chain reaction assay to be applied to routine formalin-fixed paraffin-embedded samples, integrating genes expressed by the tumor cells and their microenvironment. The significance of 30 genes chosen on the basis of previously published data was evaluated in 282 samples (divided into estimation and validation sets) to build a molecular risk score to predict failure. Adequate reverse-transcription polymerase chain reaction profiles were obtained from 262 of 282 cases (92.9%). Best predictor genes were integrated into an 11-gene model, including 4 functional pathways (cell cycle, apoptosis, macrophage activation, and interferon regulatory factor 4) able to identify low- and high-risk patients with different rates of 5-year failure-free survival: 74% versus 44.1% in the estimation set (P < .001) and 67.5% versus 45.0% in the validation set (P = .022). This model can be combined with stage IV into a final predictive model able to identify a group of patients with very bad outcome (5-year failure-free survival probability, 25.2%).
PDF
